YDC-101

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameYDC-101
Drug Alias NameYDC-101
ClassificationOther
Mechanisms of ActionStem cell growth factor receptor inhibitors
TargetsStem cell growth factor receptor
Therapy Area/IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYd Global Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYd Global Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A